The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Cabaletta Bio Inc (NASDAQ: CABA) was $1.25 for the day, down -5.30% from the previous closing price of $1.32. In other words, the price has decreased by -$5.30 from its previous closing price. On the day, 0.53 million shares were traded. CABA stock price reached its highest trading level at $1.33 during the session, while it also had its lowest trading level at $1.25.
Ratios:
Our analysis of CABA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.15 and its Current Ratio is at 6.15. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 20, 2024, Downgraded its rating to In-line and sets its target price to $6 from $15 previously.
On December 19, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $6.
On October 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $10.UBS initiated its Buy rating on October 10, 2024, with a $10 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 63428876 and an Enterprise Value of -84933120.
Stock Price History:
The Beta on a monthly basis for CABA is 2.72, which has changed by -0.89911216 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $13.50, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -17.98%, while the 200-Day Moving Average is calculated to be -62.79%.
Shares Statistics:
CABA traded an average of 1.02M shares per day over the past three months and 559800 shares per day over the past ten days. A total of 50.74M shares are outstanding, with a floating share count of 46.16M. Insiders hold about 9.03% of the company’s shares, while institutions hold 71.41% stake in the company. Shares short for CABA as of 1744675200 were 5797838 with a Short Ratio of 5.67, compared to 1741910400 on 6229073. Therefore, it implies a Short% of Shares Outstanding of 5797838 and a Short% of Float of 12.97.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Cabaletta Bio Inc (CABA) is currently under the scrutiny of 6.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.59, with high estimates of -$0.08 and low estimates of -$0.73.
Analysts are recommending an EPS of between -$1.22 and -$2.88 for the fiscal current year, implying an average EPS of -$2.29. EPS for the following year is -$2.19, with 7.0 analysts recommending between -$0.85 and -$3.17.
